The role of the gut microbiome on the efficacy of immune checkpoint inhibitors in Japanese responder patients with advanced non-small cell lung cancer/Experiment 1/Signature 2

From BugSigDB
Reviewed Marked as Reviewed by Fatima on 2022/09/7

Curated date: 2022/09/02

Curator: Sharmilac

Revision editor(s): Sharmilac, Fatima

Source: Figure 2

Description: The differential abundant taxa in the gut microbiomes of R (green) and NR (red) was analyzed by linear discriminate analysis coupled with effect size measurements (LEfSe)

Abundance in Group 1: decreased abundance in Responders

NCBI Quality ControlLinks
Bilophila
Parabacteroides
Sutterella
Alphaproteobacteria
Alcaligenaceae
Betaproteobacteria
Burkholderiales
Porphyromonadaceae

Revision editor(s): Sharmilac, Fatima